Status | Study |
Recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008) Condition: Pneumococcal Infections Date: 2016-12-06 Interventions: Biological: V114 Lot 1 Lot 1: |
Completed |
Study Name: A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax Condition: Pneumococcal Infection Date: 2015-10-06 Interventions: Biological: PnuBioVax Three ad |
Completed |
Study Name: Pneumonia Vaccine in Aging HIV Positive Individuals Condition: Pneumococcal Infection Date: 2015-09-16 Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine |
Completed |
Study Name: Immune Response to Pneumococcal Vaccination in HIV Infected Individuals Condition: Pneumococcal Infection Date: 2015-07-07 Interventions: Biological: PPV23 23 valent pneumococcal polysaccharide vaccine in Healthy adults. |
Active, not recruiting |
Study Name: Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers Condition: Pneumococcal Infection Date: 2014-10-16 Interventions: Biological: Pneumo 23® 0,5 |
Completed |
Study Name: Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) Condition: Pneumococcal Infection Date: 2014-10-06 Interventions: Biological: PNEUMOVAX™ 23 PNEUMOVAX™ 23 (23-Valent Pneumococcal Polysaccharide Vaccination, |
Completed |
Study Name: A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine Condition: Pneumococcal Infection Date: 2012-07-19 Interventions: Biological: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein] Prevnar 13 (PCV13) 13-v |
Completed |
Study Name: A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China Condition: Pneumococcal Infection Date: 2012-07-11 Interventions: Biological: 7-valent Pneumococcal Conjugate Vaccine |
Completed |
Study Name: A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects Condition: Pneumococcal Infection Date: 2011-08-12 Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine suspension in prefilled syringe for intramuscular i |
Completed |
Study Name: 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico Condition: Pneumococcal Infections Date: 2011-06-22 Interventions: Biological: vaccine-13vPnC Single dose of 0.5 ml of 13vPnC administered in deltoid muscle of arm at visi |